Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 5/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.42 |
| ▸ | NAAA | Q02083 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.39 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 5/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL111427 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL110462 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL112352 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL111061 | 0.92 | NAAA (0.53) | ALDH1A1TSHRHCAR2NAAAEPHX1 | |
| SCHEMBL111432 | 0.86 | HCAR2 (0.39) | ALDH1A1ATMTSHRHCAR2TDP1 | |
| SCHEMBL11442079 | 0.85 | NAAA (0.47) | TSHRHCAR2NAAAEPHX1SMN1; SMN2 | |
| SCHEMBL74371 | 0.79 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL8637991 | 0.79 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL10731279 | 0.79 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL9504230 | 0.79 | ALDH1A1 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10000659-B2 | Insulating layer-forming composition and use thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2018-06-19 | — | — | US | claimed |
| US-20150275031-A1 | INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-10-01 | — | — | US | claimed |
| CN-102802605-A | Stable lipid formulations of apoptosis promoters | ABBOTT LAB | 2012-11-28 | — | — | CN | claimed |
| EP-2424499-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | Abbott Laboratories (US) | 2012-03-07 | — | — | EP | claimed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | claimed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | claimed |
| US-12351659-B2 | Curable composition comprising a photoinitiator | ARKEMA FRANCE (FR) | 2025-07-08 | — | — | US | disclosed |
| US-20240199770-A1 | CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR | ARKEMA FRANCE (FR) | 2024-06-20 | — | — | US | disclosed |
| US-10000659-B2 | Insulating layer-forming composition and use thereof | HILTI AKTIENGESELLSCHAFT (LI) | 2018-06-19 | — | — | US | disclosed |
| US-20150275031-A1 | INSULATING LAYER-FORMING COMPOSITION AND USE THEREOF | HILTI AKTIENGESELLSCHAFT (LI) | 2015-10-01 | — | — | US | disclosed |
| CN-102802605-B | Stable lipid formulations of apoptosis promoters | ABBVIE (US) | 2015-08-12 | — | — | CN | disclosed |
| US-8927009-B2 | ABT-263 capsule | ABBVIE INC. (US) | 2015-01-06 | — | — | US | disclosed |
| US-8728516-B2 | Stabilized lipid formulation of apoptosis promoter | ABBVIE INC. (US) | 2014-05-20 | — | — | US | disclosed |
| WO-2010127198-A1 | FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | disclosed |
| WO-2010127193-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | disclosed |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | ABBVIE INC. | 2010-11-04 | — | — | US | disclosed |
| WO-2010127190-A1 | SALT OF ABT-263 AND SOLID-STATE FORMS THEREOF | ABBOTT LABORATORIES (US) | 2010-11-04 | — | — | WO | disclosed |
| US-7642371-B2 | Process for preparing dialkyl thiodiglycolates | SALTIGO GMBH (DE) | 2010-01-05 | — | — | US | disclosed |
| US-20090163736-A1 | PROCESS FOR PREPARING DIALKYL THIODIGLYCOLATES | SALTIGO GMBH (DE) | 2009-06-25 | — | — | US | disclosed |
| EP-2072499-A1 | Method for manufacturing thiodiglycolic dialkyl esters | Saltigo GmbH (DE) | 2009-06-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12351659-B2 | Curable composition comprising a photoinitiator | EED, CDH1, EPB41 | ALDH1A1 1379/4885ATM 1324/4885TSHR 4782/4885 |
| US-20100278905-A1 | STABILIZED LIPID FORMULATION OF APOPTOSIS PROMOTER | BCL2, BAX, BCOR | ALDH1A1 3985/4885ATM 2737/4885TSHR 4319/4885 |
| US-20240199770-A1 | CURABLE COMPOSITION COMPRISING A PHOTOINITIATOR | EED, CDH1, EPB41 | ALDH1A1 1379/4885ATM 1324/4885TSHR 4782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.